Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Remtec Search

    The specialist European Medical Device and Life Science recruitment company, working internationally to assist candidates and clients from across the world. Remtec offers 2 main services: Executive search and Contingency selection focusing on sales, marketing and technical roles. Our extensive experience, combined with proven processes, allows us to offer an unprecedented service to employers seeking top quality candidates and to candidates seeking top quality employers.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    - PMLiVE

    M3 (EU)

    M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

    View Profile

    Digital communications, Medical education, Recruitment and career development

    Company Details

    Remtec Search
    Remtec Search and Selection Ltd, Registered Office, Breaks House, Mill Court, Cambridge, CB22 5LD, United Kingdom
    +44 (0)1223 550 860
    Contact Remtec Search
    Website

     Latest Content from PMHub 

    6 trends shaping the future of personalized medicine

    White Papers and Resources | August 1, 2022 | Avalere Health

    Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

    Virtual product launch planning: the ultimate playbook

    White Papers and Resources | August 1, 2022 | Impetus Digital

    We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

    Innovative Trials opens first US office

    Videos and Podcasts | August 1, 2022 | Innovative Trials

    We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

    Artificial Intelligence for Identifying and Monitoring Cognitive Decline

    Videos and Podcasts | July 28, 2022 | Impetus Digital

    Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

    OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

    Press Releases | July 28, 2022 | OPEN Health

    OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

    The Sofa Sessions – The First Page

    Videos and Podcasts | July 27, 2022 | Page & Page Health

    Be Patient

    White Papers and Resources | July 27, 2022 | Page & Page Health

    Awareness raising is key to boosting patient involvement and engendering trust.

    Abstract Highlights from EHA 2022 : A Spotlight on CLL

    Press Releases | July 26, 2022 | Medscape Education

    Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...

    Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

    Press Releases | July 26, 2022 | Medscape Education

    Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...

    Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

    White Papers and Resources | July 25, 2022 | Impetus Digital

    While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...